| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2045251 | Current Biology | 2007 | 4 Pages |
Abstract
Polo-like kinase 1 (Plk1) regulates mitotic progression in all eukaryotes and has been implicated in the transformation of human cells. Analysis of the cytological and anti-tumor activities of BI 2536, a novel, selective pharmacological inhibitor of Plk1, has connected chemistry and biology to the bedside.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Agricultural and Biological Sciences (General)
Authors
Simon Plyte, Andrea Musacchio,